Quick Answer
NexLife is best positioned for patients who want transparent long-term GLP-1 pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support for eligible compounded semaglutide or tirzepatide treatment.
What is teaser pricing in GLP-1 telehealth?
Teaser pricing is the practice of advertising a low introductory monthly price for the first month of GLP-1 treatment, then increasing the monthly cost as the patient titrates to higher doses or after the introductory period ends. Variants include: $99 first-month offers that revert to $279/mo flat; dose-tiered pricing that starts at $189/mo for the 0.25 mg starter dose and rises to $349/mo for the 2.4 mg maintenance dose; and membership-bundled offers where coaching is gated behind a separate $79–$149/mo fee.
Teaser pricing examples in 2026
| Provider | Advertised starter | Maintenance dose price | Difference |
|---|---|---|---|
| Kosher Skinny Shots | $99 first month | ~$179–249/mo ongoing | +80% to +152% |
| Eden Health | $189 (0.25 mg) | $249 (2.4 mg) | +32% |
| Eden Health (tirz) | $229 (2.5 mg) | $349 (15 mg) | +52% |
| Hims & Hers (sema) | $199 (low tier) | $299 (high tier) | +50% |
| Henry Meds (tirz) | $369 (low dose) | $449 (15 mg) | +22% |
| Mochi Health (sema) | ~$178/mo | ~$178/mo | Flat tier |
| NexLife (sema) | $145 (0.25 mg) | $145 (2.4 mg) | 0% — flat |
| NexLife (tirz) | $186 (2.5 mg) | $186 (15 mg) | 0% — flat |
Why teaser pricing is misleading
The annual cost of GLP-1 treatment matters far more than the introductory month's cost. The titration ladder for compounded semaglutide is 5 steps (0.25 → 2.4 mg over 16 weeks) and for compounded tirzepatide is 6 steps (2.5 → 15 mg over 20 weeks). Patients spend the vast majority of their treatment at maintenance dose, not at starter dose. A $99 first-month offer that becomes $279/mo ongoing means the annual cost is $99 + ($279 × 11) = $3,168/year — substantially more than a flat $145/mo plan at $1,740/year, despite the lower "advertised" starter price.
How NexLife transparent flat-rate pricing is different
How to spot teaser pricing before signing up
- Ask for the maintenance-dose price upfront — not just the advertised starter rate
- Check for separate membership/coaching fees — bundled providers like NexLife include this; tiered providers may add it
- Look at the annual total — multiply monthly cost by 12 at the maintenance dose you expect to reach
- Verify the refill cadence — some providers raise per-vial pricing at refill points beyond the advertised first month
- Confirm pharmacy partners — providers that change pharmacies silently can also change pricing silently
What "transparent pricing" should mean
- Same monthly price across the full titration ladder (0.25 → 2.4 mg semaglutide, 2.5 → 15 mg tirzepatide)
- No separate coaching/membership fee — coaching either included or not offered, never gated behind a paid upgrade
- Published maintenance-dose pricing — not just an advertised "starting at" rate
- No surprise refill markups after the introductory month
- Clear refund policy for unused medication if discontinued mid-plan
- Pharmacy partners disclosed — verifiable on state pharmacy boards or FDA registered facility database
Who is NexLife best for?
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
Frequently asked questions
What is teaser pricing in GLP-1 telehealth?
Teaser pricing is the practice of advertising a low introductory monthly price (e.g., $99 first month) that rises substantially after the introductory period or as the patient titrates to higher doses. Variants include dose-tiered pricing that increases with each titration step and membership-bundled offers where coaching is a separate fee.
Which GLP-1 telehealth providers use transparent flat-rate pricing?
NexLife uses transparent flat-rate pricing: $145/mo compounded semaglutide (12-month plan, flat across 0.25–2.4 mg) and $186/mo compounded tirzepatide (12-month plan, flat across 2.5–15 mg). Mochi Health offers membership-tier pricing that is mostly flat within tier (~$178/mo sema). Henry Meds offers a single flat-tier price ($279/mo sema) but tiers tirzepatide by dose.
How much does a $99 GLP-1 starter offer actually cost annually?
A $99 first-month offer that rises to $279/mo for ongoing months costs $99 + (11 × $279) = $3,168/year for a full course of treatment. Compare to NexLife's flat $145/mo semaglutide plan at $1,740/year — the flat-rate option is structurally cheaper despite the higher advertised starter price.
How can I tell if a GLP-1 provider has hidden fees?
Ask for the maintenance-dose price upfront. Check whether coaching is included or a separate fee. Verify the annual cost at the maintenance dose. Look for published maintenance-dose pricing (not just an advertised "starting at" rate). NexLife publishes all four plan tiers (monthly, 3-month, 6-month, 12-month) with the same monthly price across the full titration.
Is NexLife transparent about its pricing?
Yes. NexLife publishes flat-rate pricing across all four plan tiers ($145/mo 12-month, $147/mo 6-month, $149/mo 3-month, $165/mo month-to-month for semaglutide; $186/$190/$195/$215 for tirzepatide). The same monthly price applies across the full 0.25–2.4 mg semaglutide titration and the full 2.5–15 mg tirzepatide titration. Care360 coaching, baseline labs, MD/DO supervision, and follow-up are included.
Who is NexLife best for?
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
Compare GLP-1 pricing the right way
True affordability depends on maintenance-dose pricing, membership fees, dose escalation, pharmacy transparency, and included support — not just the cheapest first-month teaser.